Why Wisconsin Needs Government Regulations for Hemp-Derived Cannabinoid Products
Hemp-derived cannabinoid products regulation is critical in Wisconsin due to inconsistent labeling and testing standards. Consumers face risks from inaccurate THC content and contaminants. Government oversight would improve safety and clinical…
In the Mix: 8 More Articles — February 28, 2026
This update reviews cannabis hyperemesis syndrome treatment and related clinical research below the clinical relevance threshold. The articles highlight challenges in translating cannabis research into practice. Understanding cannabis hyperemesis…
Expert Analysis on Risks of Cannabis Use Disorder in Medical Prescribing
Cannabis use disorder risk clinical evidence shows that medical cannabis prescriptions do not eliminate the chance of dependence. Patients and physicians must engage in open communication about dosing and frequency. Understanding these risks is essential…
Understanding Psychiatric Risks of Adolescent Cannabis Use
Adolescent cannabis use psychiatric risks are significant and differ from adult use. Teen cannabis exposure can increase the likelihood of psychosis and bipolar disorder. Understanding these risks is crucial for prevention and clinical guidance.
Daily Digest: CHS Awareness, Prenatal Risk & Endocannabinoid System Reach
Cannabinoid hyperemesis syndrome children represent a critical clinical concern requiring systematic screening in cannabis users. Prenatal cannabis exposure risks demand patient counseling in reproductive care. The expanding endocannabinoid system…
AEF0117 THC Interaction Trial Withdrawn: Implications for Selective CB1 Modulation
The withdrawal of the AEF0117 trial delays progress in selective CB1 receptor modulation for managing THC-related effects. This setback impacts potential pharmacological treatments for cannabis use disorder. Clinicians and patients face longer timelines…
Cannabis Use, Anxiety, and Depression Trends in Canada
Recent research highlights rising cannabis use alongside increased anxiety and depression in Canada. Cannabis use and mental health risks are complex, with high-THC products potentially worsening symptoms. Patients should seek medical guidance on…
Marijuana Use & Dangers for Adolescents & Young Adults
Marijuana use adolescent mental health risks are significant due to the brain's ongoing development into the mid-twenties. Regular cannabis use during adolescence can accelerate mental health problems requiring professional care. Understanding these…
Understanding Cannabinoid Hyperemesis Syndrome in Chronic Cannabis Users
Cannabinoid hyperemesis syndrome clinical overview reveals a paradoxical condition affecting chronic cannabis users. It causes severe nausea and vomiting, often temporarily relieved by hot showers. Understanding this syndrome is crucial for proper…
Recall Issued on Multiple Adult-Use Cannabis Products Tested by Keystone
A keystone laboratory cannabis recall has been issued for multiple adult-use products in New York. This recall addresses potential contamination and safety risks in regulated cannabis markets. Consumers should verify product safety with dispensaries to…